Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
about
Interpretation of urine drug testing in pain patientsLaboratory testing for prescription opioidsOpioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.Bioanalytical procedures and recent developments in the determination of opiates/opioids in human biological samples.Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management.The challenges of LC-MS/MS analysis of opiates and opioids in urine.The Disposition of Oxycodone and Metabolite in Human Hair.Screening with Quantification for 64 Drugs and Metabolites in Human Urine using UPLC-MS-MS Analysis and a Threshold Accurate Calibration.Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration.Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients.Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.Re: Pergolizzi et al., 2010: the role of urine drug testing for patients on opioid therapy.Urinary hydrocodone and metabolite distributions in pain patients.Observations of urinary oxycodone and metabolite distributions in pain patients.Definitive Drug and Metabolite Screening in Urine by UPLC-MS-MS Using a Novel Calibration Technique.A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.Capillary electrophoresis combined in-line with solid-phase extraction using magnetic particles as new adsorbents for the determination of drugs of abuse in human urine.Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis.
P2860
Q27011889-C4F956D5-021C-41AD-9B68-B2D7FE4E700FQ27015926-0511D9BE-2F48-448B-B126-60DD40478FD9Q33688813-6AD6FFB5-89D1-435F-8D3A-56B3A907D3E0Q37858459-C5C2FF51-B04D-4703-A217-BFBD3A122F71Q38154663-6A7C7D85-5049-4EFA-A077-8843C5198EA9Q38164427-E52F4403-E9FB-44BA-ACC9-2125D7727E0DQ38547770-68425951-8ED8-400B-BA6C-DD0A427B475BQ38765515-C9FE33B1-A417-4A51-8CB6-370E612FA0F1Q39609516-B547A53C-60C4-4E9D-B97A-6E60F8E63DB1Q39609528-60DB1F03-5126-4E2E-A5E0-E55230416100Q40984910-9B021A8C-A68E-4324-8045-C0F33D2900A1Q41581475-10ADE851-6648-48F7-8C63-B34812EF344FQ44351321-9E00C020-9000-4955-8835-0C06AA188545Q46065047-47B23DE5-AD85-4F8D-9191-33D1A90940BAQ46121183-DE1C477F-D52F-4368-9AAB-21652E378F55Q47394735-B068C200-F695-4316-A7D8-F072182282FAQ47615995-12C483A1-A1A7-4504-936F-6F5F5DE34ADEQ50586416-7D19D7F0-7E93-4779-BC2E-17E6E9B1F29FQ50882407-C96AEC1F-2755-4513-9B6E-5B75D3A6A4CCQ51431838-C7F853AE-2CAB-4FA1-97D1-18A4FFE0DFE8
P2860
Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Urine drug testing of chronic ...... ption opiates and metabolites.
@en
Urine drug testing of chronic ...... ption opiates and metabolites.
@nl
type
label
Urine drug testing of chronic ...... ption opiates and metabolites.
@en
Urine drug testing of chronic ...... ption opiates and metabolites.
@nl
prefLabel
Urine drug testing of chronic ...... ption opiates and metabolites.
@en
Urine drug testing of chronic ...... ption opiates and metabolites.
@nl
P2093
P356
P1476
Urine drug testing of chronic ...... ption opiates and metabolites.
@en
P2093
Anne Zichterman
Beverly Cawthon
David L Black
Edward J Cone
Frank Moser
Rebecca Heltsley
Tim Robert
Yale H Caplan
P356
10.1093/JAT/34.1.32
P577
2010-01-01T00:00:00Z